The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Tauchi, Ryoji ^a   Imagama, Shiro ^a   Natori, Takamitsu ^a   Ohgomori, Tomohiro ^a   Muramoto, Akio ^a   Shinjo, Ryuichi ^a   Matsuyama, Yukihiro ^b   Ishiguro, Naoki ^a   Kadomatsu, Kenji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ADAMTS 4; Chondroitin sulfate proteoglycan; Extracellular matrix; Keratan sulfate proteoglycan; Rat; Spinal cord injury

Indexed keywords

AGGRECANASE 1; BREVICAN; NEUROCAN; PHOSPHACAN; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG; ADAM PROTEIN; AGGRECANASE-1; CSPG2 PROTEIN, RAT; PROCOLLAGEN N PROTEINASE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; VERSICAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; FUNCTIONAL STATUS; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MICROGLIA; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE SPROUTING; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; ANIMAL; CELL CULTURE; CEREBELLUM; CONVALESCENCE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; MOTOR ACTIVITY; NERVE CELL; NEURITE; NEWBORN; PSYCHOMOTOR PERFORMANCE; SPRAGUE DAWLEY RAT;

ADAM PROTEINS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BREVICAN; CELLS, CULTURED; CEREBELLUM; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; MOTOR ACTIVITY; NEURITES; NEUROCAN; NEURONS; PROCOLLAGEN N-ENDOPEPTIDASE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; VERSICANS;

EID: 84858142863     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-53     Document Type: Article

References (48)

1. Widenfalk J, Lundstromer K, Jubran M, Brene S, Olson L. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 2001, 21:3457-3475.
2. Neumann S, Woolf CJ. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron 1999, 23:83-91. 10.1016/S0896-6273(00)80755-2, 10402195.
3. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003, 4:703-713. 10.1038/nrn1195, 12951563.
4. McGee AW, Strittmatter SM. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci 2003, 26:193-198. 10.1016/S0166-2236(03)00062-6, 12689770.
5. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol 2004, 14:118-124. 10.1016/j.conb.2004.01.004, 15018947.
6. De Winter F, Holtmaat AJ, Verhaagen J. Neuropilin and class 3 semaphorins in nervous system regeneration. Adv Exp Med Biol 2002, 515:115-139. 10.1007/978-1-4615-0119-0_10, 12613548.
7. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156. 10.1038/nrn1326, 14735117.
8. Moon LD, Asher RA, Rhodes KE, Fawcett JW. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci 2001, 4:465-466.
9. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640. 10.1038/416636a, 11948352.
10. Zhang H, Muramatsu T, Murase A, Yuasa S, Uchimura K, Kadomatsu K. N-acetylglucosamine 6-O-sulfotransferase-1 is required for brain keratan sulfate biosynthesis and glial scar formation after brain injury. Glycobiology 2006, 16:702-710. 10.1093/glycob/cwj115, 16624895.
11. Ito Z, Sakamoto K, Imagama S, Matsuyama Y, Zhang H, Hirano K, Ando K, Yamashita T, Ishiguro N, Kadomatsu K. N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J Neurosci 2010, 30:5937-5947. 10.1523/JNEUROSCI.2570-09.2010, 20427653.
12. Smith GM, Rutishauser U, Silver J, Miller RH. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Dev Biol 1990, 138:377-390. 10.1016/0012-1606(90)90204-V, 2318341.
13. Allaman I, Pellerin L, Magistretti PJ. Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes. J Neurochem 2004, 88:900-908.
14. Giulian D, Baker TJ, Shih LC, Lachman LB. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986, 164:594-604. 10.1084/jem.164.2.594, 2188228, 3487617.
15. Ughrin YM, Chen ZJ, Levine JM. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J Neurosci 2003, 23:175-186.
16. Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K, Arner EC, Hockfield S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem 2000, 275:22695-22703. 10.1074/jbc.M909764199, 10801887.
17. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, Rockwell A, Yang F, Duke JL, Solomon K, George H, Bruckner R, Nagase H, Itoh Y, Ellis DM, Ross H, Wiswall BH, Murphy K, Hillman MC, Hollis GF, Newton RC, Magolda RL, Trzaskos JM, Arner EC. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284:1664-1666. 10.1126/science.284.5420.1664, 10356395.
18. Niiya M, Uemura M, Zheng XW, Pollak ES, Dockal M, Scheiflinger F, Wells RG, Zheng XL. Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. J Thromb Haemost 2006, 4:1063-1070. 10.1111/j.1538-7836.2006.01893.x, 2577223, 16689760.
19. Kim JE, Liu BP, Park JH, Strittmatter SM. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004, 44:439-451. 10.1016/j.neuron.2004.10.015, 15504325.
20. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 1997, 238:53-56. 10.1016/S0304-3940(97)00859-8, 9464653.
21. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195. 10.1161/01.STR.29.10.2189, 9756602.
22. Jiang X, Namura S, Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 2001, 305:41-44. 10.1016/S0304-3940(01)01800-6, 11356303.
23. Cardenas A, Moro MA, Leza JC, O'Shea E, Davalos A, Castillo J, Lorenzo P, Lizasoain I. Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cereb Blood Flow Metab 2002, 22:1297-1302.
24. Wang X, Feuerstein GZ, Xu L, Wang H, Schumacher WA, Ogletree ML, Taub R, Duan JJ, Decicco CP, Liu RQ. Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol 2004, 65:890-896. 10.1124/mol.65.4.890, 15044618.
25. Collins-Racie LA, Flannery CR, Zeng W, Corcoran C, Annis-Freeman B, Agostino MJ, Arai M, DiBlasio-Smith E, Dorner AJ, Georgiadis KE, et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 2004, 23:219-230. 10.1016/j.matbio.2004.05.004, 15296936.
26. Somerville RP, Longpre JM, Jungers KA, Engle JM, Ross M, Evanko S, Wight TN, Leduc R, Apte SS. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 2003, 278:9503-9513. 10.1074/jbc.M211009200, 12514189.
27. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, Clowes AW. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 2001, 276:13372-13378. 10.1074/jbc.M009737200, 11278559.
28. Ruoslahti E. Brain extracellular matrix. Glycobiology 1996, 6:489-492. 10.1093/glycob/6.5.489, 8877368.
29. Fukatsu K, Bannai H, Inoue T, Mikoshiba K. Lateral diffusion of inositol 1,4,5-trisphosphate receptor type 1 in Purkinje cells is regulated by calcium and actin filaments. J Neurochem 2010, 114:1720-1733. 10.1111/j.1471-4159.2010.06885.x, 20626556.
30. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251. 10.1126/science.1072699, 12424383.
31. Gogolla N, Caroni P, Luthi A, Herry C. Perineuronal nets protect fear memories from erasure. Science 2009, 325:1258-1261. 10.1126/science.1174146, 19729657.
32. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000, 57:276-289. 10.1007/PL00000690, 10766023.
33. Rhodes KE, Fawcett JW. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J Anat 2004, 204:33-48. 10.1111/j.1469-7580.2004.00261.x, 1571240, 14690476.
34. Vankemmelbeke MN, Jones GC, Fowles C, Ilic MZ, Handley CJ, Day AJ, Knight CG, Mort JS, Buttle DJ. Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem 2003, 270:2394-2403. 10.1046/j.1432-1033.2003.03607.x, 12755694.
35. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J 2005, 386:15-27. 10.1042/BJ20040424, 1134762, 15554875.
36. Imagama S, Sakamoto K, Tauchi R, Shinjo R, Ohgomori T, Ito Z, Zhang H, Nishida Y, Asami N, Takeshita S, Sugiura N, Watanabe H, Yamashita T, Ishiguro N, Matsuyama Y, Kadomatsu K. Keratan sulfate restricts neural plasticity after spinal cord injury. J Neurosci 2011, 31:17091-17102. 10.1523/JNEUROSCI.5120-10.2011, 22114278.
37. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 1994, 125:669-680. 10.1083/jcb.125.3.669, 2119998, 7513709.
38. Yamada H, Watanabe K, Shimonaka M, Yamaguchi Y. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem 1994, 269:10119-10126.
39. Grumet M, Flaccus A, Margolis RU. Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J Cell Biol 1993, 120:815-824. 10.1083/jcb.120.3.815, 2119543, 8425902.
40. Milev P, Friedlander DR, Sakurai T, Karthikeyan L, Flad M, Margolis RK, Grumet M, Margolis RU. Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 1994, 127:1703-1715. 10.1083/jcb.127.6.1703, 2120309, 7528221.
41. Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 2000, 113:807-816.
42. Dou CL, Levine JM. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J Neurosci 1994, 14:7616-7628.
43. Jones LL, Margolis RU, Tuszynski MH. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003, 182:399-411. 10.1016/S0014-4886(03)00087-6, 12895450.
44. Cross AK, Haddock G, Stock CJ, Allan S, Surr J, Bunning RA, Buttle DJ, Woodroofe MN. ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Brain Res 2006, 1088:19-30. 10.1016/j.brainres.2006.02.136, 16630594.
45. Nakamura H, Fujii Y, Inoki I, Sugimoto K, Tanzawa K, Matsuki H, Miura R, Yamaguchi Y, Okada Y. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J Biol Chem 2000, 275:38885-38890.
46. Cross AK, Haddock G, Surr J, Plumb J, Bunning RA, Buttle DJ, Woodroofe MN. Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis. J Autoimmun 2006, 26:16-23. 10.1016/j.jaut.2005.09.026, 16303287.
47. Yuan W, Matthews RT, Sandy JD, Gottschall PE. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 2002, 114:1091-1101.
48. Hamel MG, Ajmo JM, Leonardo CC, Zuo F, Sandy JD, Gottschall PE. Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension. Exp Neurol 2008, 210:428-440. 10.1016/j.expneurol.2007.11.014, 2614334, 18178186.